HB 2321: Uniform Controlled Substances Act
- Session Year: 2025-2026
- House: House
- Latest Version Date: 2026-03-04
Current Status:
Failed
(2026-03-12: Referred to HHS, JDC.)
Introduced
In Committee
First Chamber
In Committee
Second Chamber
Final Decking
Enacted
Updates the Uniform Controlled Substances Act to make it consistent with amendments in the Federal Controlled Substances Act as required under state law. (HD1)
Updates chapter 329, HRS, to make it consistent with amendments in the Federal Controlled Substances Act as required under section 329-11, HRS.
|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
2321 |
|
THIRTY-THIRD LEGISLATURE, 2026 |
H.D. 1 |
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows:
1. By amending subsection (b) to read:
"(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
(2) Acetylmethadol;
(3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), its optical, positional, and geometric isomers, salts, and salts of isomers;
(4) Acryl fentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide] (Other name: acryloylfentanyl);
(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide);
(6) Allylprodine;
(7) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM);
(8) Alphameprodine;
(9) Alphamethadol;
(10) Alpha'-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
(11) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);
(12) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(13) Benzethidine;
(14) Benzylfentanyl (N-[1-benzyl-4-piperidyl]-N- phenylpropanamide), its optical isomers, salts, and salts of isomers;
(15) Betacetylmethadol;
(16) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
(17) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
(18) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);
(19) Betameprodine;
(20) Betamethadol;
(21) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide) (Other name: [beta]-methyl fentanyl);
(22) Beta-methylacetyl fentanyl (N -phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide);
[(22)] (23) Beta'-phenyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other names: [beta]'-phenyl fentanyl; 3-phenylpropanoyl
fentanyl);
[(23)] (24) Betaprodine;
[(24)] (25) Brorphine (1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one);
[(25)] (26)
Butonitazene
(2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine);
[(26)] (27)
Butyryl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);
[(27)] (28)
Clonitazene;
[(28)] (29)
Crotonyl fentanyl
((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide);
[(29)] (30)
Cyclopentyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);
[(30)] (31)
Cyclopropyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
[(31)] (32)
Dextromoramide;
[(32)] (33)
Diampromide;
[(33)] (34)
Diethylthiambutene;
[(34)] (35)
Difenoxin;
[(35)] (36)
Dimenoxadol;
[(36)] (37)
Dimepheptanol;
[(37)] (38)
2',5'-dimethoxyfentanyl
(N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);
[(38)] (39) Dimethylthiambutene;
[(39)] (40) Dioxaphetyl butyrate;
[(40)] (41) Dipipanone;
[(41)] (42) Ethylmethylthiambutene;
[(42)] (43) Etodesnitazene
(2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) (Other
name: etazene);
[(43)] (44) Etonitazene;
[(44)] (45) Etoxeridine;
[(45)] (46) Fentanyl carbamate (ethyl
(1-phenethylpiperidin-4-yl)(phenyl)carbamate);
[(46)] (47)
Flunitazene
(N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);
[(47)] (48)
4-fluoroisobutyryl fentanyl
[N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (Other
name: para-fluoroisobutyryl fentanyl);
[(48)] (49)
2'-fluoro ortho-fluorofentanyl
(N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide) (Other
name: 2'-fluoro 2-fluorofentanyl);
[(49)] (50)
Furanyl fentanyl
(N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide);
[(50)] (51)
3-furanyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);
[(51)] (52)
Furethidine;
[(52)] (53)
Hydroxypethidine;
[(53)] (54)
Isobutyryl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide);
[(54)] (55)
Isotonitazene
(N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);
[(55)] (56)
Isovaleryl fentanyl
(3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
[(56)] (57)
Ketobemidone;
[(57)] (58)
Levomoramide;
[(58)] (59)
Levophenacylmorphan;
[(59)] (60)
Meta-fluorofentanyl
(N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
(61) Meta-fluorofuranyl fentanyl (N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
[(60)] (62)
Meta-fluoroisobutyryl fentanyl
(N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
[(61)] (63) Methoxyacetyl fentanyl
(2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
[(62) 2-methyl
AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);
(63)] (64) 4'-methyl acetyl fentanyl
(N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide);
(65) 2-methyl AP-237 (1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);
[(64)] (66) 3-methylfentanyl
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
[(65)] (67) 3-methylthiofentanyl
(N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
[(66)] (68)
Metodesnitazene
(N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine);
[(67)] (69)
Metonitazene
(N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);
[(68)] (70) Morpheridine;
[(69)] (71) MPPP
(1-methyl-4-phenyl-4-propionoxypiperidine);
[(70)] (72) MT-45
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);
[(71)] (73) Noracymethadol;
[(72)] (74) Norlevorphanol;
[(73)] (75) Normethadone;
[(74)] (76) Norpipanone;
[(75)] (77) N-pyrrolidino etonitazene
(2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)
(Other name: etonitazepyne);
(78) N-pyrrolidino metonitazene (2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole) (Other name: metonitazepyne);
(79) N-pyrrolidino protonitazene (5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole) (Other name: protonitazepyne);
[(76)] (80) Ocfentanil
[N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide];
(81) Ortho-chlorofentanyl (N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
[(77)] (82) Ortho-fluoroacryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide);
[(78)] (83) Ortho-fluorobutyryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) (Other name: 2-fluorobutyryl fentanyl);
[(79)] (84) Ortho-fluorofentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other
name: 2-fluorofentanyl);
[(80)] (85) Ortho-fluorofuranyl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
[(81)] (86) Ortho-fluoroisobutyryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
[(82)] (87) Ortho-methyl acetylfentanyl
(N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl acetylfentanyl);
(88) Ortho-methylcyclopropyl fentanyl (N-(2-methylphenyl)- N -(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
[(83)] (89) Ortho-methyl methoxyacetyl fentanyl
(2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other
name: 2-methyl methoxyacetyl fentanyl);
(90) Para-chlorofentanyl (N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
[(84)] (91) Para-chloroisobutyryl fentanyl
(N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
[(85)] (92)
Para-fluorobutyryl fentanyl
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
[(86)] (93)
Para-fluorofentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide);
[(87)] (94) Para-fluoro furanyl fentanyl
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
(95) Para-fluoro valeryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide);
[(88)] (96)
Para-methoxybutyryl fentanyl
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
[(89)] (97)
Para-methoxyfuranyl fentanyl
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
[(90)] (98)
Para-methylcyclopropyl fentanyl
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
[(91)] (99) Para-methylfentanyl
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other
name: 4-methylfentanyl);
[(92)] (100) PEPAP
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
[(93)] (101) Phenadoxone;
[(94)] (102) Phenampromide;
[(95)] (103) Phenomorphan;
[(96)] (104) Phenoperidine;
[(97)] (105) Phenyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide) (Other name: benzoyl fentanyl);
[(98)] (106)
Piritramide;
[(99)] (107)
Proheptazine;
[(101)] (109) Propiram;
[(102)] (110) Protonitazene
(N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine);
[(103)] (111)
Racemoramide;
[(104)] (112)
Tetrahydrofuranyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
(113) Tetrahydrothiofuranyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrothiophene-2-carboxamide) (Other name: tetrahydrothiophene fentanyl);
[(105)] (114) Thenylfentanyl
(N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide), its optical isomers,
salts, and salts of isomers;
[(106)] (115) Thiofentanyl
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
[(107)] (116) Thiofuranyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide) (Other
names: 2-thiofuranyl fentanyl; thiophene
fentanyl);
[(108)] (117) Tilidine;
[(109)] (118) Trimeperidine;
[(110)] (119) U-47700
(3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide); and
[(111)] (120)
Valeryl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide)."
2. By amending subsection (e) to read:
"(e) Depressants.
Unless specifically excepted[, the schedule shall include] or
unless listed in another schedule, any material, compound, mixture, or
preparation [which] that contains any quantity of the [substance:]
following substances having a depressant effect on the central nervous
system, including its salts, isomers, and salts of isomers, whenever the
existence of the salts, isomers, and salts of isomers is possible within the
specific chemical designation:
[(1) Mecloqualone;
(2) Methaqualone;]
(1) Clonazolam (6-(2-chlorophenyl)-1-methyl-8-nitro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine);
(2) Diclazepam (7-chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-benzo[e][1,4]diazepin-2-one);
(3) Etizolam (4-(2-chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine)
(including its optical, positional, and geometric isomers, salts, and salts of
isomers, where possible); [or]
(4) Flualprazolam (8-chloro-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine)
(including its optical, positional, and geometric isomers, salts, and salts of
isomers, where possible)[.];
(5) Flubromazolam (8-bromo-6-(2-fluorophenyl)-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine);
(6) Mecloqualone; or
(7) Methaqualone."
SECTION 2. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 3. This Act shall take effect on July 1, 2026.
Report Title:
Uniform Controlled Substances Act
Description:
Updates the Uniform Controlled Substances Act to make it consistent with amendments in the Federal Controlled Substances Act as required under state law. (HD1)
The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
|
HOUSE OF REPRESENTATIVES |
H.B. NO. |
2321 |
|
THIRTY-THIRD LEGISLATURE, 2026 |
|
|
|
STATE OF HAWAII |
|
|
|
|
|
|
|
|
||
|
|
||
A BILL FOR AN ACT
RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT.
BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF HAWAII:
SECTION 1. Section 329-14, Hawaii Revised Statutes, is amended as follows:
(1) By amending subsection (b) to read as follows:
"(b) Opiates. Unless specifically excepted or unless listed in another schedule, any of the following opiates, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, whenever the existence of these isomers, esters, ethers, and salts is possible within the specific chemical designation:
(1) Acetyl-alpha-methylfentanyl (N-[1-(1-methyl-2-phenethyl)-4-piperidinyl]-N-phenylacetamide);
(2) Acetylmethadol;
(3) Acetyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide), its optical, positional, and geometric isomers, salts, and salts of isomers;
(4) Acryl fentanyl [N-(1-phenethylpiperidin-4-yl)-N-phenylacrylamide] (Other name: acryloylfentanyl);
(5) AH-7921 (3,4-dichloro-N-[(1-dimethylamino)cyclohexylmethyl]benzamide);
(6) Allylprodine;
(7) Alphacetylmethadol (except levo-alphacetylmethadol, levomethadyl acetate, or LAAM);
(8) Alphameprodine;
(9) Alphamethadol;
(10) Alpha'-methyl butyryl fentanyl (2-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
(11) Alpha-methylfentanyl (N-[1-(alpha-methyl-beta-phenyl)ethyl-4-piperidyl]propionanilide; 1-(1-methyl-2-phenylethyl)-4-(N-propanilido)piperidine);
(12) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
(13) Benzethidine;
(14) Benzylfentanyl (N-[1-benzyl-4-piperidyl]-N- phenylpropanamide), its optical isomers, salts, and salts of isomers;
(15) Betacetylmethadol;
(16) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperidinyl]-N-phenylpropanamide);
(17) Beta-hydroxy-3-methylfentanyl (N-[1-(2-hydroxy-2-phenethyl)-3-methyl-4-piperidinyl]-N-phenylpropanamide);
(18) Beta-hydroxythiofentanyl (N-[1-[2-hydroxy-2-(thiophen-2-yl)ethyl]piperidin-4-yl]-N-phenylpropionamide);
(19) Betameprodine;
(20) Betamethadol;
(21) Beta-methyl fentanyl (N-phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)propionamide) (Other name: [beta]-methyl fentanyl);
(22) Beta-methylacetyl fentanyl N -phenyl-N-(1-(2-phenylpropyl)piperidin-4-yl)acetamide;
[(22)] (23) Beta'-phenyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N,3-diphenylpropanamide) (Other names: [beta]'-phenyl fentanyl; 3-phenylpropanoyl
fentanyl);
[(23)] (24) Betaprodine;
[(24)] (25) Brorphine
(1-(1-(1-(4-bromophenyl)ethyl)piperidin-4-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-one);
[(25)] (26) Butonitazene
(2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine);
[(26)] (27) Butyryl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylbutyramide);
[(27)] (28) Clonitazene;
[(28)] (29) Crotonyl fentanyl
((E)-N-(1-phenethylpiperidin-4-yl)-N-phenylbut-2-enamide);
[(29)] (30) Cyclopentyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopentanecarboxamide);
[(30)] (31) Cyclopropyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylcyclopropanecarboxamide);
[(31)] (32) Dextromoramide;
[(32)] (33) Diampromide;
[(33)] (34) Diethylthiambutene;
[(34)] (35) Difenoxin;
[(35)] (36) Dimenoxadol;
[(36)] (37) Dimepheptanol;
[(37)] (38) 2',5'-dimethoxyfentanyl
(N-(1-(2,5-dimethoxyphenethyl)piperidin-4-yl)-N-phenylpropionamide);
[(38)] (39) Dimethylthiambutene;
[(39)] (40) Dioxaphetyl butyrate;
[(40)] (41) Dipipanone;
[(41)] (42) Ethylmethylthiambutene;
[(42)] (43) Etodesnitazene
(2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine) (Other
name: etazene);
[(43)] (44) Etonitazene;
[(44)] (45) Etoxeridine;
[(45)] (46) Fentanyl carbamate (ethyl
(1-phenethylpiperidin-4-yl)(phenyl)carbamate);
[(46)] (47) Flunitazene
(N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);
[(47)] (48) 4-fluoroisobutyryl fentanyl
[N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide] (Other
name: para-fluoroisobutyryl fentanyl);
[(48)] (49) 2'-fluoro ortho-fluorofentanyl
(N-(1-(2-fluorophenethyl)piperidin-4-yl)-N-(2-fluorophenyl)propionamide) (Other
name: 2'-fluoro 2-fluorofentanyl);
[(49)] (50) Furanyl fentanyl
(N-(1-phenethylpiperidin-4-y1)-N-phenylfuran-2-carboxamide);
[(50)] (51) 3-furanyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylfuran-3-carboxamide);
[(51)] (52) Furethidine;
[(52)] (53) Hydroxypethidine;
[(53)] (54) Isobutyryl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylisobutyramide);
[(54)] (55) Isotonitazene
(N,N-diethyl-2-(2-(4-isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);
[(55)] (56) Isovaleryl fentanyl
(3-methyl-N-(1-phenethylpiperidin-4-yl)-N-phenylbutanamide);
[(56)] (57) Ketobemidone;
[(57)] (58) Levomoramide;
[(58)] (59) Levophenacylmorphan;
[(59)] (60) Meta-fluorofentanyl
(N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide);
(61) Meta-Fluorofuranyl fentanyl N-(3-fluorophenyl)- N -(1-phenethylpiperidin-4-yl)furan-2-carboxamide;
[(60)] (62) Meta-fluoroisobutyryl fentanyl
(N-(3-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
[(61)] (63) Methoxyacetyl fentanyl
(2-methoxy-N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide);
[(62)] (64) 2-methyl AP-237
(1-(2-methyl-4-(3-phenylprop-2-en-1-yl)piperazin-1-yl)butan-1-one);
[(63)] (65) 4'-methyl acetyl fentanyl
(N-(1-(4-methylphenethyl)piperidin-4-yl)-N-phenylacetamide);
[(64)] (66) 3-methylfentanyl
(N-[3-methyl-1-(2-phenylethyl)-4-piperidyl]-N-phenylpropanamide);
[(65)] (67) 3-methylthiofentanyl
(N-[3-methyl-1-(2-thienyl)ethyl-4-piperidinyl]-N-phenylpropanamide);
[(66)] (68) Metodesnitazene
(N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine);
[(67)] (69) Metonitazene
(N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine);
[(68)] (70) Morpheridine;
[(69)] (71) MPPP
(1-methyl-4-phenyl-4-propionoxypiperidine);
[(70)] (72) MT-45
(1-cyclohexyl-4-(1,2-diphenylethyl)piperazine);
[(71)] (73) Noracymethadol;
[(72)] (74) Norlevorphanol;
[(73)] (75) Normethadone;
[(74)] (76) Norpipanone;
[(75)] (77) N-pyrrolidino etonitazene
(2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole)
(Other name: etonitazepyne);
(78) N-pyrrolidino metonitazene 2-(4-methoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (Other name: Metonitazepyne);
(79) 5-nitro-2-(4-propoxybenzyl)-1-(2-(pyrrolidin-1-yl)ethyl)-1 H -benzimidazole)(Other name: Protonitazepyne);
[(76)] (80) Ocfentanil
[N-(2-fluorophenyl)-2-methoxy-N-(1-phenethylpiperidin-4-yl)acetamide];
(81) Ortho-Chlorofentanyl N-(2-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide;
[(77)] (82) Ortho-fluoroacryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)acrylamide);
[(78)] (83) Ortho-fluorobutyryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide) (Other name: 2-fluorobutyryl fentanyl);
[(79)] (84) Ortho-fluorofentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other
name: 2-fluorofentanyl);
[(80)] (85) Ortho-fluorofuranyl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
[(81)] (86) Ortho-fluoroisobutyryl fentanyl
(N-(2-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
[(82)] (87) Ortho-methyl acetylfentanyl
(N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other name: 2-methyl acetylfentanyl);
[(83)] (88) Ortho-methyl methoxyacetyl fentanyl
(2-methoxy-N-(2-methylphenyl)-N-(1-phenethylpiperidin-4-yl)acetamide) (Other
name: 2-methyl methoxyacetyl fentanyl);
(89) Ortho-methylcyclopropylfentanyl N-(2-methylphenyl)- N -(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide;
(90) Para-Chlorofentanyl N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)propionamide;
[(84)] (91) Para-chloroisobutyryl fentanyl
(N-(4-chlorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide);
[(85)] (92) Para-fluorobutyryl fentanyl
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
[(86)] (93) Para-fluorofentanyl
(N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4-piperidinyl]propanamide[;]);
[(87)] (94) Para-fluoro furanyl fentanyl
(N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
(95) Para-fluoro valeryl fentanyl N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)pentanamide;
[(88)] (96) Para-methoxybutyryl fentanyl
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)butyramide);
[(89)] (97) Para-methoxyfuranyl fentanyl
(N-(4-methoxyphenyl)-N-(1-phenethylpiperidin-4-yl)furan-2-carboxamide);
[(90)] (98) Para-methylcyclopropyl fentanyl
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)cyclopropanecarboxamide);
[(91)] (99)
Para-methylfentanyl
(N-(4-methylphenyl)-N-(1-phenethylpiperidin-4-yl)propionamide) (Other
name: 4-methylfentanyl);
[(92)] (100) PEPAP
(1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine);
[(93)] (101) Phenadoxone;
[(94)] (102)
Phenampromide;
[(95)] (103)
Phenomorphan;
[(96)] (104) Phenoperidine;
[(97)] (105)
Phenyl fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylbenzamide) (Other
name: benzoyl fentanyl);
[(98)] (106)
Piritramide;
[(99)] (107) Proheptazine;
[(101)] (109)
Propiram;
[(102)] (110)
Protonitazene
(N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine);
[(103)] (111) Racemoramide;
[(104)] (112) Tetrahydrofuranyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenyltetrahydrofuran-2-carboxamide);
(113) Tetrahydrothiofuranyl fentanyl N -(1-phenethylpiperidin-4-yl)- N -phenyltetrahydrothiophene-2-carboxamide;
[(105)] (114) Thenylfentanyl
(N-[1-(2-thienyl)methyl-4-piperidyl]-N-phenylpropanamide), its optical isomers,
salts, and salts of isomers;
[(106)] (115) Thiofentanyl
(N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-propanamide);
[(107)] (116) Thiofuranyl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylthiophene-2-carboxamide) (Other
names: 2-thiofuranyl fentanyl; thiophene
fentanyl);
[(108)] (117) Tilidine;
[(109)] (118) Trimeperidine;
[(110)] (119)
U-47700
(3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide); and
[(111)] (120)
Valeryl fentanyl
(N-(1-phenethylpiperidin-4-yl)-N-phenylpentanamide)."
(2) By amending subsection (e) to read as follows:
"(e) Depressants.
Unless specifically excepted, the schedule shall include any material,
compound, mixture, or preparation [which] that contains any
quantity of the substance:
[(1) Mecloqualone;
(2) Methaqualone;]
(1) Clonazolam;
(2) Diclazepam;
(3) Etizolam (including its
optical, positional, and geometric isomers, salts, and salts of isomers, where
possible); [or]
(4) Flualprazolam (including
its optical, positional, and geometric isomers, salts, and salts of isomers,
where possible)[.];
(6) Mecloqualone; or
(7) Methaqualone."
SECTION 2. Statutory material to be repealed is bracketed and stricken. New statutory material is underscored.
SECTION 3. This Act, upon its approval, shall take effect on July 1, 2026.
|
INTRODUCED BY: |
_____________________________ |
|
|
BY REQUEST |
Report Title:
Uniform Controlled Substances Act
Description:
Updates chapter 329, HRS, to make it consistent with amendments in the Federal Controlled Substances Act as required under section 329-11, HRS.
The summary description of legislation appearing on this page is for informational purposes only and is not legislation or evidence of legislative intent.
|
Date
|
Status
|
|---|---|
| Mar 12, 2026 | Referred to HHS, JDC. |
| Mar 12, 2026 | Passed First Reading. |
| Mar 12, 2026 | Received from House (Hse. Com. No. 397). |
| Mar 10, 2026 | Passed Third Reading with none voting aye with reservations; none voting no (0) and Representative(s) Kong, Pierick excused (2). Transmitted to Senate. |
| Mar 5, 2026 | Passed Second Reading as amended in HD 1; placed on the calendar for Third Reading with none voting aye with reservations; none voting no (0) and Representative(s) Perruso excused (1). |
| Mar 5, 2026 | Reported from JHA (Stand. Com. Rep. No. 902-26) as amended in HD 1, recommending passage on Second Reading and placement on the calendar for Third Reading. |
| Feb 24, 2026 | The committee on JHA recommend that the measure be PASSED, WITH AMENDMENTS. The votes were as follows: 8 Ayes: Representative(s) Tarnas, Poepoe, Belatti, Cochran, Kahaloa, Sayama, Takayama, Shimizu; Ayes with reservations: none; 0 Noes: none; and 2 Excused: Representative(s) Hashem, Garcia. |
| Feb 20, 2026 | Bill scheduled to be heard by JHA on Tuesday, 02-24-26 2:00PM in House conference room 325 VIA VIDEOCONFERENCE. |
| Feb 13, 2026 | Re-referred to JHA, referral sheet 13 |
| Feb 2, 2026 | Referred to HLT, JHA, referral sheet 6 |
| Jan 28, 2026 | Introduced and Pass First Reading. |
| Jan 26, 2026 | Pending introduction. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Mar 10, 2026 | Third Reading | House Floor |
Passed |
|
| Feb 24, 2026 | The committee on JHA recommend that the measure be PASSED, WITH AMENDMENTS | House Standing Committee on Judiciary & Hawaiian Affairs |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
|
Organization
|
Position
|
Date
|
|---|---|---|
| Department of Law Enforcement | ** Support |
STAND. COM. REP. NO. 902-26
Honolulu, Hawaii
, 2026
RE: H.B. No. 2321
H.D. 1
Honorable Nadine K. Nakamura
Speaker, House of Representatives
Thirty-Third State Legislature
Regular Session of 2026
State of Hawaii
Madame:
Your Committee on Judiciary & Hawaiian Affairs, to which was referred H.B. No. 2321 entitled:
"A BILL FOR AN ACT RELATING TO THE UNIFORM CONTROLLED SUBSTANCES ACT,"
begs leave to report as follows:
Your Committee received testimony in support of this measure from the Department of Law Enforcement.
Your Committee finds that Hawaii's controlled substances regulatory framework is out of alignment with federal law, creating gaps that may be exploited by individuals seeking to manufacture, distribute, or possess substances that are controlled at the federal level but not by the State. This measure ensures that Hawaii's Uniform Controlled Substances Act is in alignment with the federal Controlled Substances Act.
Your Committee has amended this measure by making technical, nonsubstantive amendments for the purposes of clarity, consistency, and style.
As affirmed by the record of votes of the members of your Committee on Judiciary & Hawaiian Affairs that is attached to this report, your Committee is in accord with the intent and purpose of H.B. No. 2321, as amended herein, and recommends that it pass Second Reading in the form attached hereto as H.B. No. 2321, H.D. 1, and be placed on the calendar for Third Reading.
Respectfully submitted on behalf of the members of the Committee on Judiciary & Hawaiian Affairs,
|
|
|
____________________________ DAVID A. TARNAS, Chair |
|
|
|
|
|
Date
|
Testimony PDF
|
|---|---|
| Feb 24, 2026 | HB2321_TESTIMONY_JHA_02-24-26_.PDF |
Discussed in Hearing
1MIN
House Standing Committee on Judiciary & Hawaiian Affairs
27SEC
House Standing Committee on Judiciary & Hawaiian Affairs
Bill Author
Bill Co-Author(s):